These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19165450)

  • 1. [Bisphosphonates and osteonecrosis of the jaw--an increasing challenge in palliative care].
    Beke D; Pecherstorfer M
    Wien Med Wochenschr; 2008; 158(23-24):702-6. PubMed ID: 19165450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bisphosphonates-induced osteonecrosis of the jaw: CT-findings].
    Maksimovic O; Denecke B; Pintoffl JP; Horger M
    Rofo; 2008 Apr; 180(4):277-9. PubMed ID: 18432565
    [No Abstract]   [Full Text] [Related]  

  • 3. Bisphosphonates and osteonecrosis of the jaw.
    Purcell PM; Boyd IW
    Med J Aust; 2005 Apr; 182(8):417-8. PubMed ID: 15850440
    [No Abstract]   [Full Text] [Related]  

  • 4. Bisphosphonate-induced osteonecrosis of the jaws: a case report and literature review.
    Tsai WS; Haghighi K; Placa SJ
    Gen Dent; 2006; 54(3):215-9; quiz 220-2. PubMed ID: 16776417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteonecrosis of the jaws and bisphosphonate treatment in cancer patients.
    Wutzl A; Eisenmenger G; Hoffmann M; Czerny C; Moser D; Pietschmann P; Ewers R; Baumann A
    Wien Klin Wochenschr; 2006 Aug; 118(15-16):473-8. PubMed ID: 16957978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk.
    Kos M; Kuebler JF; Luczak K; Engelke W
    J Craniomaxillofac Surg; 2010 Jun; 38(4):255-9. PubMed ID: 19592261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonate-induced osteonecrosis of the jaws.
    Throndson RR; Healy SM; Zwickey MR
    Tex Dent J; 2005 Sep; 122(9):960-5. PubMed ID: 16320503
    [No Abstract]   [Full Text] [Related]  

  • 8. Bisphosphonates and avascular necrosis of the jaw: a possible association.
    Carter G; Goss AN; Doecke C
    Med J Aust; 2005 Apr; 182(8):413-5. PubMed ID: 15850439
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
    Hay KD; Bishop PA
    N Z Dent J; 2006 Mar; 102(1):4-9. PubMed ID: 16568881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinico-pathologic correlation. Bisphosphonate-related osteonecrosis of the jaws.
    Oreadi D; Papageorge MB
    J Mass Dent Soc; 2010; 58(4):34-7. PubMed ID: 20225801
    [No Abstract]   [Full Text] [Related]  

  • 11. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE; Blake FA
    Anticancer Res; 2007; 27(4A):1841-5. PubMed ID: 17649782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.
    Migliorati CA; Schubert MM; Peterson DE; Seneda LM
    Cancer; 2005 Jul; 104(1):83-93. PubMed ID: 15929121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer.
    Sanna G; Preda L; Bruschini R; Cossu Rocca M; Ferretti S; Adamoli L; Verri E; Franceschelli L; Goldhirsch A; Nolè F
    Ann Oncol; 2006 Oct; 17(10):1512-6. PubMed ID: 16936182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.
    Merigo E; Manfredi M; Meleti M; Corradi D; Vescovi P
    J Oral Pathol Med; 2005 Nov; 34(10):613-7. PubMed ID: 16202082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws.
    Biasotto M; Chiandussi S; Dore F; Rinaldi A; Rizzardi C; Cavalli F; Di Lenarda R
    Acta Odontol Scand; 2006 Nov; 64(6):348-54. PubMed ID: 17123911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Osteonecrosis of the jaw developing during bisphosphonate treatment].
    Udvardy E; Redl P; Márton I
    Magy Onkol; 2008 Mar; 52(1):81-7. PubMed ID: 18403302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe spontaneous cases of bisphosphonate-related osteonecrosis of the jaws.
    Herbozo PJ; Briones DL; Ferres AJ; Torrealba RL
    J Oral Maxillofac Surg; 2007 Aug; 65(8):1650-4. PubMed ID: 17656297
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral bisphosphonates and CTX. New methods for assessing the degree of risk in maxillo-mandibular osteonecrosis].
    Blanc JL; Chossegros C
    Rev Stomatol Chir Maxillofac; 2008 Jun; 109(3):205-6. PubMed ID: 18533207
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals.
    Magopoulos C; Karakinaris G; Telioudis Z; Vahtsevanos K; Dimitrakopoulos I; Antoniadis K; Delaroudis S
    Am J Otolaryngol; 2007; 28(3):158-63. PubMed ID: 17499130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endodontic implications of bisphosphonate-associated osteonecrosis of the jaws: a report of three cases.
    Katz H
    J Endod; 2005 Nov; 31(11):831-4. PubMed ID: 16249730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.